Lornoxicam tablets
Form: Oral Tablets
Strength: 4 mg, 8 mg
Reference Brands: Xefo (EU)
Category: Analgesic
Lornoxicam tablets are approved in the EU for managing pain and inflammation, regulated by EMA with dossiers demonstrating safety, efficacy, and manufacturing quality. In the US, lornoxicam is not approved and is not marketed. In the EU, brands like Xefo (by Orion) are supported by comprehensive clinical data, with ongoing pharmacovigilance. For expert assistance with regulatory dossiers, compliance, and registration, visit PharmaTradz. We support efficient market access for lornoxicam tablets, ensuring adherence to European standards for safe, effective pain management, helping you navigate complex regulatory pathways seamlessly.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Related Products
Dexketoprofen + Tramadol tablets
Strength: 25 mg dexketoprofen + 37.5 mg tramadol
Form: Tablets
Reference Brands: Enantyum(EU)
View Details Get Enquiry
Paracetamol + Codeine tablets
Strength: 300 mg paracetamol + 30 mg codeine; 300 mg + 60 mg
Form: Tablets
Reference Brands: Tylenol with Codeine(US)
View Details Get Enquiry
Aceclofenac + Paracetamol tablets
Strength: 100 mg Aceclofenac + 325 mg Paracetamol
Form: Tablets
Reference Brands: Generic formulations marketed under different names
View Details Get Enquiry
Tramadol + Paracetamol tablets
Strength: 37.5 mg tramadol + 325 mg paracetamol; 75 mg + 650 mg
Form: Oral Tablets
Reference Brands: Ultracet(US); Tramacet(EU)
View Details Get Enquiry